Detection of unknown primary head and neck tumors by positron emission tomography

International Journal of Oral and Maxillofacial Surgery

Volumn 26, Issue 2, 1997, Pages 112-115

  Braams, J W ^a   Pruim, J ^a   Kole, A C ^a   Nikkels, P G J ^a   Vaalburg, W ^a   Vermey, A ^a   Roodenburg, J L N ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cancer; PET; Unknown primary tumors

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHUS TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HEAD AND NECK TUMOR; HUMAN; LYMPH NODE METASTASIS; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; PLASMACYTOMA; SCINTISCANNING; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BRONCHIAL NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PLASMACYTOMA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031109848     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0901-5027(05)80829-X     Document Type: Article

References (17)

1. ABBRUZZESE JL, ABBRUZZESE MC, HESS KR, et al. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994: 12: 1272-80.
2. BRAAMS JW, PRUIM J, FRELING NJM, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995: 36: 211-6.
3. VAN DEN BREKEL MWM, STEL HV, CASTELIJNS JA, et al. Cervical lymph node metastasis: assessment of radiologie criteria. Radiology 1990: 177: 379-84.
4. GRECO FA, HAINSWORTH JD. Cancer of unknown primary site. In: DEVITA VT, HELLMAN S, ROSENBERG SA, eds.: Cancer: principles and practice of oncology. 4th ed. Philadelphia: JB Lippencott, 1993: 2072-92.
5. HABERKORN U, STRAUSS LG, REISSER CH, et al. Glucose uptake, perfusion and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med 1991: 32: 1548-55.
6. HAMACHER K, COENEN HH, STÖCKLIN G. Efficient stereospecific synthesis of nocarrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986: 27: 235-8.
7. HOLMES FF, FOUTS TL. Metastatic cancer of unknown primary site. Cancer 1970: 26: 816-20.
8. JABOUR BA, CHOI Y, HOH CK, et al. Extracranial head and neck; PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993: 186: 27-35.
9. KARSELL PR, SHEEDY PF, O'CONNELL MJ. Computerized tomography in search of cancer of unknown origin. JAMA 1982: 248: 340-3.
10. KOLE AC, NIEWEG OE. Toepassingen van positron-emissietomografie in de oncologie. Ned Tijdschr Geneeskd 1996: 140: 244-8.
11. MCMILLAN JH, LEVINE E, STEPHENS RH. Computed tomography in the evaluation of metastatic adenocarcinoma from an unknown primary site. Radiology 1982: 143: 143-6.
12. MCLOUD TC, BOURGOUIN PM, GREENBERG RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992: 182: 319-23.
13. MINN H, JOENSUU H, AHONEN A, KLEMI P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Cancer 1988: 61: 1776-81.
14. RICHARDSON RG, PARKER RG. Metastases from undetected primary cancers: clinical experience at a radiation oncology center. West J Med 1975: 113: 337-9.
15. SMITH PE, KREMENTZ ET, CHAPMAN W. Metastatic cancer without a detectable primary site. Am J Surg 1967: 113: 633-7.
16. STEINKAMPP HJ, KNÖBBER D, ZWICKER C, et al. Halslymphknotenmetastasen bei unbekanntem primärtumor: Gibt es eine bildgebende Differentialdiagnostik? Laryngorhinootologie 1993: 72: 78-85.
17. WAHL RL, KAMINSKI MS, ETHIER SP, HUTCHINS GD. The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. J Nucl Med 1990: 31: 1831-5.